254 related articles for article (PubMed ID: 31581514)
21. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ
Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967
[TBL] [Abstract][Full Text] [Related]
22. Cellular uptake and biological activity of peptide nucleic acids conjugated with peptides with and without cell-penetrating ability.
Turner Y; Wallukat G; Säälik P; Wiesner B; Pritz S; Oehlke J
J Pept Sci; 2010 Jan; 16(1):71-80. PubMed ID: 19943337
[TBL] [Abstract][Full Text] [Related]
23. A peptide-based dendrimer that enhances the splice-redirecting activity of PNA conjugates in cells.
Hassane FS; Ivanova GD; Bolewska-Pedyczak E; Abes R; Arzumanov AA; Gait MJ; Lebleu B; Gariépy J
Bioconjug Chem; 2009 Aug; 20(8):1523-30. PubMed ID: 19591462
[TBL] [Abstract][Full Text] [Related]
24. Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates.
Koppelhus U; Awasthi SK; Zachar V; Holst HU; Ebbesen P; Nielsen PE
Antisense Nucleic Acid Drug Dev; 2002 Apr; 12(2):51-63. PubMed ID: 12074365
[TBL] [Abstract][Full Text] [Related]
25. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
[TBL] [Abstract][Full Text] [Related]
26. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
27. CLIP6-PNA-Peptide Conjugates: Non-Endosomal Delivery of Splice Switching Oligonucleotides.
Soudah T; Mogilevsky M; Karni R; Yavin E
Bioconjug Chem; 2017 Dec; 28(12):3036-3042. PubMed ID: 29211451
[TBL] [Abstract][Full Text] [Related]
28. Intracellular delivery of a peptide nucleic acid-based hybrid of an autophagy inducing peptide with a cell-penetrating peptide.
Hakata Y; Ishikawa S; Ohtsuki T; Miyazawa M; Kitamatsu M
Org Biomol Chem; 2020 Mar; 18(10):1978-1986. PubMed ID: 32104826
[TBL] [Abstract][Full Text] [Related]
29. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
Wolf Y; Pritz S; Abes S; Bienert M; Lebleu B; Oehlke J
Biochemistry; 2006 Dec; 45(50):14944-54. PubMed ID: 17154532
[TBL] [Abstract][Full Text] [Related]
30. Uptake, Stability, and Activity of Antisense Anti-
Yavari N; Goltermann L; Nielsen PE
ACS Chem Biol; 2021 Mar; 16(3):471-479. PubMed ID: 33684286
[TBL] [Abstract][Full Text] [Related]
31. In Vitro Cellular Delivery of Peptide Nucleic Acid (PNA).
Shiraishi T; Ghavami M; Nielsen PE
Methods Mol Biol; 2020; 2105():173-185. PubMed ID: 32088870
[TBL] [Abstract][Full Text] [Related]
32. Novel peptide (RATH) mediated delivery of peptide nucleic acids for antiviral interventions.
Joshi VG; Chindera K; Bais MV; Sajjanar B; Tiwari AK; Kumar S
Appl Microbiol Biotechnol; 2021 Sep; 105(18):6669-6677. PubMed ID: 34427763
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial Activity of Peptide-Coupled Antisense Peptide Nucleic Acids in Streptococcus pneumoniae.
Barkowsky G; Abt C; Pöhner I; Bieda A; Hammerschmidt S; Jacob A; Kreikemeyer B; Patenge N
Microbiol Spectr; 2022 Dec; 10(6):e0049722. PubMed ID: 36321914
[TBL] [Abstract][Full Text] [Related]
34. Developments in Cell-Penetrating Peptides as Antiviral Agents and as Vehicles for Delivery of Peptide Nucleic Acid Targeting Hepadnaviral Replication Pathway.
Ndeboko B; Hantz O; Lemamy GJ; Cova L
Biomolecules; 2018 Jul; 8(3):. PubMed ID: 30013006
[TBL] [Abstract][Full Text] [Related]
35. Flavin conjugates for delivery of peptide nucleic acids.
Marlin F; Simon P; Bonneau S; Alberti P; Cordier C; Boix C; Perrouault L; Fossey A; Saison-Behmoaras T; Fontecave M; Giovannangeli C
Chembiochem; 2012 Nov; 13(17):2593-8. PubMed ID: 23129496
[TBL] [Abstract][Full Text] [Related]
36. Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells.
Shiraishi T; Hamzavi R; Nielsen PE
Nucleic Acids Res; 2008 Aug; 36(13):4424-32. PubMed ID: 18596083
[TBL] [Abstract][Full Text] [Related]
37. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
38. Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.
Deuss PJ; Arzumanov AA; Williams DL; Gait MJ
Org Biomol Chem; 2013 Nov; 11(43):7621-30. PubMed ID: 24105028
[TBL] [Abstract][Full Text] [Related]
39. Effective Cellular Delivery of Antisense Peptide Nucleic Acid by Conjugation to Guanidinylated Diaminobutanoic Acid-Based Peptide Dendrons.
Gabas IM; Nielsen PE
Biomacromolecules; 2020 Feb; 21(2):472-483. PubMed ID: 31756087
[TBL] [Abstract][Full Text] [Related]
40. Electroporation-based delivery of cell-penetrating peptide conjugates of peptide nucleic acids for antisense inhibition of intracellular bacteria.
Ma S; Schroeder B; Sun C; Loufakis DN; Cao Z; Sriranganathan N; Lu C
Integr Biol (Camb); 2014 Oct; 6(10):973-8. PubMed ID: 25160797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
